No. 7 / 2026Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate ...

Last patient visits for both OCS-01 Phase 3 DIAMOND trials (total 800+ patients) are complete, with topline results expected in June 2026 A non-invasive topical treatment for diabetic macular edema ...

U of A School of Art's M.A. degree program in Art History, specializing in Arts of the Americas, will host its second annual symposium, featuring five graduate students whose works span diverse time ...

The Beijing half-marathon race record time for a humanoid robot of 50 minutes 26 seconds is almost two hours quicker than the ...

Cascadia Liquor introduces The Den Rewards loyalty program across 12 locations, offering points, perks, and personalized ...

Greystone Capital reports a +1.4% net return for Q1 2026, outperforming the S&P 500. Read the full analysis for more details ...

End Zone Eats is a benefit for Weekend Backpacks, a non-profit serving food insecure students in Maryland, and Jimmy's Famous ...

Dallas Cowboys’ former QB Troy Aikman’s role in the franchise remains huge, but Dak Prescott is slowly taking the mantle, ...

Centennial Ice Arena in Billings wrapped up its final chapter during the third annual Guns and Hoses charity hockey game on ...

HeART of Portland was first produced in 2015 as a way to show the public where money from the Portland Arts Tax is being put ...

Gainesville’s The Streatery project began construction April 13. The $4.5 million project will transform Southwest First ...

ALXN1840 has demonstrated a well-characterized and favorable safety profile across Phase 2 and Phase 3 studies (266 patients; median 2.58 years on treatment; max >8 years), with drug-related serious ...